| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |